Precigen (PGEN) Long-Term Debt Repayments (2012 - 2023)

Precigen (PGEN) reported Long-Term Debt Repayments of $13.9 million for Q2 2023, up 12193.81% year-over-year from N/an in Q2 2022, and down 52.63% quarter-over-quarter from $29.3 million in Q1 2023.

Precigen (PGEN) Long-Term Debt Repayments (2012 - 2023) Analysis & Trends

Precigen (PGEN) has 12 years of Long-Term Debt Repayments data on file, last reported at $13.9 million in Q2 2023.

  • Long-Term Debt Repayments for Q2 2023 came in at $13.9 million, up 12193.81% year-over-year; the trailing twelve-month figure through Mar 2024 was $13.9 million (down 92.47% YoY), and the FY2023 annual result was $43.2 million, down 72.17% from the prior year.
  • Long-Term Debt Repayments retreated to $13.9 million in Q2 2023 per PGEN's latest filing, from $29.3 million in the prior quarter.
  • Over five years, Long-Term Debt Repayments peaked at $115.7 million in Q3 2022 and troughed at $113000.0 in Q2 2022.
  • A 5-year average of $11.1 million and a median of $137500.0 in 2019 frame the typical range for Long-Term Debt Repayments.
  • The sharpest annual moves came in 2019 and 2022: Long-Term Debt Repayments slipped 29.9% in 2019, then jumped 98817.95% in 2022.
  • A 5-year view of Long-Term Debt Repayments shows it stood at $154000.0 in 2019, then retreated by 22.08% to $120000.0 in 2020, then declined by 4.17% to $115000.0 in 2021, then soared by 34058.26% to $39.3 million in 2022, then sank by 64.64% to $13.9 million in 2023.
  • Business Quant data shows PGEN's Long-Term Debt Repayments at $13.9 million in Q2 2023, $29.3 million in Q1 2023, and $39.3 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -21,671.00
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn -
9 Abivax 94.37 Bn 94.37 Bn - -
10 Precigen 1.27 Bn 1.27 Bn 20.69 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2023 13.89 Mn
Jun 30, 2023 13.89 Mn
Mar 31, 2023 29.33 Mn
Mar 31, 2023 29.33 Mn
Dec 31, 2022 39.28 Mn
Dec 31, 2022 39.28 Mn
Sep 30, 2022 115.73 Mn
Sep 30, 2022 115.73 Mn
Jun 30, 2022 113,000.00
Jun 30, 2022 113,000.00
Mar 31, 2022 164,000.00
Mar 31, 2022 164,000.00
Dec 31, 2021 115,000.00
Dec 31, 2021 115,000.00
Sep 30, 2021 117,000.00
Sep 30, 2021 117,000.00
Jun 30, 2021 118,000.00
Jun 30, 2021 118,000.00
Mar 31, 2021 116,000.00
Mar 31, 2021 116,000.00